We offer the most innovative solution for acute myocardial infarction (AMI) diagnostics

06 March 2023
Semetron AS

Semetron, in co-operation with device manufacturer Siemens Healthineers, offers the most innovative solution for acute myocardial infarction (AMI) diagnostics – the Atellica® VTL. The device is able to determine high-sensitivity troponin I levels in capillary whole blood in a near-patient setting in just 8 minutes. The Atellica® VTLi wireless device can be easily integrated into the workflow of hospitals and clinics. The new solution will help streamline primary diagnostics in overcrowded emergency care centres.

Vaata lähemalt

More news

Company news
News
Effective rescue logistics with Frestems

We are pleased to announce that we have expanded our... View Article

Company news
News
Semetron’s success: record sales of Linet in Estonia

We are proud to share a notable achievement: as a... View Article

Company news
News
Introducing new bariatric manikin: R42

Introducing the latest addition to our portfolio: the R42 bariatric... View Article